Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 41,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $150.52 Daily Weekly Monthly
20 Day Moving Average: 1,035,810 shares
Shares Outstanding: 80.76 (millions)
Market Capitalization: $12,155.52 (millions)
Beta: 1.17
52 Week High: $347.72
52 Week Low: $125.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.34% -1.33%
12 Week 8.04% -8.82%
Year To Date -28.23% -32.56%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/23/25
Share - Related Items
Shares Outstanding: 80.76
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.17
Market Capitalization: $12,155.52 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.23 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $12.67 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 6.45% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/23/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 11.88
Trailing 12 Months: 11.30
PEG Ratio: 1.84
Price Ratios
Price/Book: 1.28
Price/Cash Flow: 7.51
Price / Sales: 1.48
EPS Growth
vs. Year Ago Period: -9.17%
vs. Previous Quarter: -10.23%
Sales Growth
vs. Year Ago Period: -4.26%
vs. Previous Quarter: -1.95%
ROE
06/30/25 - -
03/31/25 - 11.46
12/31/24 - 11.81
ROA
06/30/25 - -
03/31/25 - 6.49
12/31/24 - 6.65
Current Ratio
06/30/25 - -
03/31/25 - 1.27
12/31/24 - 1.26
Quick Ratio
06/30/25 - -
03/31/25 - 1.27
12/31/24 - 1.26
Operating Margin
06/30/25 - -
03/31/25 - 13.42
12/31/24 - 13.66
Net Margin
06/30/25 - -
03/31/25 - 9.25
12/31/24 - 9.56
Pre-Tax Margin
06/30/25 - -
03/31/25 - 10.10
12/31/24 - 10.49
Book Value
06/30/25 - -
03/31/25 - 117.65
12/31/24 - 117.92
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.36
12/31/24 - 0.36
Debt-to-Capital
06/30/25 - -
03/31/25 - 26.30
12/31/24 - 26.29
 

Powered by Zacks Investment Research ©